Reckitt Benckiser’s Mead Johnson unit and Abbott Laboratories have been ordered to face a new trial in the US over ...

Reckitt Benckiser is moving forward with the sale of its nutrition operations housing the Mead Johnson infant-formula ...

Reckitt Benckiser is continuing to assess options for its nutrition operations housing the Mead Johnson infant-formula business. After describing nutrition as "non-core" in July as part of a ...

Back in October, a jury found North Chicago-based Abbott and Reckitt’s formula subsidiary, Mead Johnson, not responsible for a baby developing necrotizing enterocolitis, or NEC, from their cow ...

Shares in Reckitt were down 2.8%, and those in Abbott fell 2.9% at 1440 GMT. Noble said Abbott and Mead Johnson's lawyers intentionally and repeatedly violated clear instructions when presenting ...

Reckitt, whose products include Nurofen tablets ... surrounding an infant nutrition product made by its U.S.-based Mead Johnson business. A lawsuit had accused the company of failing to warn ...

Mead Johnson is deciding whether to invest in Zeeland or elsewhere in the country, the city wrote in a news release.

Turning now to our new operating structure, going forward, we'll be reporting through three segments: Core Reckitt, Essential Home and Mead Johnson Nutrition. We use the term Core Reckitt for now ...

Reckitt Benckiser’s Mead Johnson unit and Abbott Laboratories have been ordered to face a new trial in the US over allegations their premature infant formula can cause a serious gut condition.